Jie Chen
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 37
- Pancreatic and Hepatic Oncology Research 27
- Cancer Research top 2%
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 25
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 13
- Immunology top 5%
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 10
-
- Neuroendocrine Tumor Research Advances 16
-
- Lung Cancer Treatments and Mutations 9
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jie Chen
224 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 154
- Oncology 1.4k
- Cancer Research 646
- Obstetrics and Gynecology 313
- Reproductive Medicine 290
- Immunology 709
Countries citing papers authored by Jie Chen
This map shows the geographic impact of Jie Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Chen more than expected).
Fields of papers citing papers by Jie Chen
This network shows the impact of papers produced by Jie Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Chen. The network helps show where Jie Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 15 | |
| 4 | 2024 | 16 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 29 | |
| 7 | 2022 | 15 | |
| 8 | 2022 | 25 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 18 | |
| 12 | 2020 | 37 | |
| 13 | 2020 | 23 | |
| 14 | 2019 | 27 | |
| 15 | 2017 | 10 | |
| 16 | [Clinicopathological characteristics and prognosis analysis of colorectal neuroendocrine neoplasms based on the data from domestic six medical centers]. | 2016 | 2 |
| 17 | 2015 | 55 | |
| 18 | 2014 | 37 | |
| 19 | 2013 | 45 | |
| 20 | Studies on Anti-tumor Activities of Enteromorpha Chlorella Growth Factor in Experimental Liver Cancer and its Mechanism | 2009 | 1 |
About Jie Chen
Jie Chen is a scholar working on Oncology, Obstetrics and Gynecology and Nephrology, having authored 244 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (37 papers), Pancreatic and Hepatic Oncology Research (27 papers), Endometrial and Cervical Cancer Treatments (25 papers), Neuroendocrine Tumor Research Advances (16 papers), Ovarian cancer diagnosis and treatment (13 papers), Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (10 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (646 citations) and Obstetrics and Gynecology (313 citations). Jie Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhaohui Lu, Shuangni Yu, Liju Zong, Yang Xiang, Shengwei Mo, Jian Sun, Keng Shen, Yunxiao Meng, Jiaxin Yang and Dongyan Cao. Their work appears in journals such as Nature Communications, Molecular Cell and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.